PERTH, Australia, March 23 /PRNewswire/ -- Ozgene Pty Ltd has been awarded a USD8.5 million contract from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), to supply Genetically Modified (Knock-out and Knock-In) Mice to the individual investigators in the institute.
This award has been funded in whole or in part with Federal funds from NIAID, NIH, U.S. Department of Health and Human Services, under Contract No. HHSN2722004000013D.
Ozgene's Director & CEO, Dr Frank Koentgen: "We are proud to accept the award and look forward to working with the NIH."
Please go to http://www.ozgene.com/ for more information.
Ozgene Pty Ltd
CONTACT: Contact: Press office: Ozgene Pty Ltd, +61-8-9212-2200 (Phone)